Vance Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$967K Sell
12,249
-6,604
-35% -$533K 0.22% 58
2026
Q1
$1.65M Sell
18,853
-58
-0.3% -$5.56K 0.48% 43
2025
Q4
$1.83M Sell
18,911
-5,255
-22% -$510K 0.54% 43
2025
Q3
$2.32M Sell
24,166
-183
-0.8% -$16.8K 0.71% 38
2025
Q2
$2.12M Sell
24,349
-55
-0.2% -$4.66K 0.72% 37
2025
Q1
$2.19M Sell
24,404
-4,899
-17% -$438K 0.82% 32
2024
Q4
$2.34M Buy
29,303
+33
+0.1% +$2.86K 0.9% 27
2024
Q3
$2.64M Sell
29,270
-26,400
-47% -$2.22M 1% 24
2024
Q2
$4.38M Sell
55,670
-566
-1% -$46.4K 1.8% 13
2024
Q1
$4.9M Sell
56,236
-20,182
-26% -$1.72M 1.95% 14
2023
Q4
$6.3M Buy
76,418
+19,473
+34% +$1.48M 2.73% 7
2023
Q3
$4.46M Sell
56,945
-2,953
-5% -$247K 2.09% 11
2023
Q2
$5.28M Sell
59,898
-2,692
-4% -$232K 2.4% 10
2023
Q1
$5.09M Sell
62,590
-258
-0.4% -$21K 2.73% 9
2022
Q4
$4.88M Buy
62,848
+53,875
+600% +$4.37M 3.05% 8
2022
Q3
$725K Sell
8,973
-75
-0.8% -$6.74K 0.56% 28
2022
Q2
$812K Sell
9,048
-1,796
-17% -$182K 0.63% 25
2022
Q1
$1.2M Buy
10,844
+144
+1% +$15.2K 1.52% 16
2021
Q4
$1.11M Buy
+10,700
New +$1.24M 1.09% 10

Other funds holding MDT

Vance Wealth's MDT Position: Q2 2026 in Review

Vance Wealth reduced its Medtronic (MDT) stake by 35% in Q2 2026, selling an estimated $533K and leaving 12,249 shares worth $967K. The position accounts for 0.22% of the portfolio, ranked #58.

Vance Wealth first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.3M in Q4 2023. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vance Wealth held 12,249 shares of Medtronic worth $967K as of Q2 2026.
  • Vance Wealth sold 6,604 Medtronic shares in Q2 2026, an estimated $533K.
  • Medtronic made up 0.22% of Vance Wealth's portfolio in Q2 2026, its #58 holding.
  • Vance Wealth first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • Vance Wealth's Medtronic position peaked at $6.3M in Q4 2023.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vance Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.